speb/financial-data huggingface dataset:
Stock screener scorecard for SHAHALLOYS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.5558656516631919 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.069775720897116%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6280767272109999%
Revenue growth: -96.48673010050626%
Rule of 40 score: -96.48673010050626
Market cap: 1317724160 (Small Cap ($300M-$2B))
P/E ratio: 0.01140768241880712
Debt to equity: 0.5606
Operating income: -78423.06061890631
Net income: -891267.4862229759
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for SOI.L (quarterly, report date 2026-02-28)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 968911424 (Small Cap ($300M-$2B))
Debt to equity: 0.038966277772247926
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SOS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18170320 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SOS (annual, report date 2025-12-31)
Altman Z-score: 1.522248660128273 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -20.953891463999792%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -23.30295567666703%
Free cash flow margin: -164.4254326268715%
Revenue growth: -30.472885884165617%
Rule of 40 score: -194.8983185110371
Market cap: 18170320 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -36241714.28571429
Operating income: -14085571.42857143
Net income: -13902714.285714285
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SRC.V (quarterly, report date 2026-03-31)
Altman Z-score: 45.02521902335893 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.010184213837647%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.514989694386548%
Free cash flow margin: -177.55203353231323%
Revenue growth: 36.73986190865867%
Rule of 40 score: -140.81217162365456
Market cap: 44827040 (Nano Cap (< $50M))
Debt to equity: 0.0441
Free cash flow (dilution adjusted): -522333.8129496403
Operating income: -376002.1582733813
Net income: -376002.1582733813
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ST5.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 261952448 (Micro Cap ($50M-$300M))
P/E ratio: 22.95766904892798
Debt to equity: 0.3845
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TRTX (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.8217098784145882%
Capitalized R&D asset: 0
Free cash flow margin: 55.506619905934805%
Revenue growth: 5.419580419580419%
Rule of 40 score: 60.926200325515225
Market cap: 666396736 (Small Cap ($300M-$2B))
P/E ratio: 11.859375
Debt to equity: 3.1664999999999996
Free cash flow (dilution adjusted): 20417000
Net income: 18939000
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TWST (quarterly, report date 2026-03-31)
Altman Z-score: 12.702825697371331 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.640628169256715%
Capitalized R&D asset: 36786720
ROCI (R&D adjusted): -6.223911430426261%
Rosenberg metric: 0.18388791593695272
Free cash flow margin: -40.17703111592829%
Revenue growth: 6.766765029219464%
Rule of 40 score: -33.41026608670882
Market cap: 5621231104 (Mid Cap ($2B-$10B))
Debt to equity: 0.24359999999999998
Free cash flow (dilution adjusted): -44482000
Operating income: -38658000
Net income: -44021000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for UOS.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1218153216 (Small Cap ($300M-$2B))
P/E ratio: 4.99627143922446
Debt to equity: 0.08470000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UOS.AX (annual, report date 2025-12-31)
Altman Z-score: 2.5990930283288987 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.692566450283943%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.25501112286181%
Free cash flow margin: 33.2841946523871%
Revenue growth: 49.068949973658924%
Rule of 40 score: 82.35314462604603
Market cap: 1218153216 (Small Cap ($300M-$2B))
P/E ratio: 4.99627143922446
Debt to equity: 0.08470000000000001
Free cash flow (dilution adjusted): 36404197.5308642
Operating income: 33309876.543209877
Net income: 54352345.67901235
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for VAR.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10059226 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for VAR.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.6681063515993%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.229085490570142%
Rule of 40 score: 0
Market cap: 10059226 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1451120.9150326797
Operating income: -585063.3986928104
Net income: -601560.1307189543
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for VGM (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 549369856 (Small Cap ($300M-$2B))
P/E ratio: 33.096774193548384
Debt to equity: 0.565
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for VGM (annual, report date 2026-02-28)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.963690157943267%
Capitalized R&D asset: 0
Free cash flow margin: -11.411598095204806%
Revenue growth: -16.89080887111668%
Rule of 40 score: -28.302406966321485
Market cap: 549369856 (Small Cap ($300M-$2B))
P/E ratio: 33.096774193548384
Debt to equity: 0.565
Free cash flow (dilution adjusted): -1991523
Net income: 17028868
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for VIS.V (quarterly, report date 2026-03-31)
Altman Z-score: -98.48381531028986 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -57.75883775761691%
Revenue growth: 81.15954948253457%
Rule of 40 score: 23.400711724917663
Market cap: 3874895 (Nano Cap (< $50M))
P/E ratio: 0.07194244604316546
Debt to equity: -1.038836562033436
Free cash flow (dilution adjusted): -108916.54676258993
Operating income: -17541.726618705037
Net income: -26403.59712230216
Long score: 2 | Short score: 11
Recommendation: Short
Stock screener scorecard for 0673.HK (annual, report date 2025-03-31)
Altman Z-score: -0.9310783553824292 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -386.5370863940714%
Free cash flow margin: -21.446729835914027%
Revenue growth: -34.6015745876616%
Rule of 40 score: -56.04830442357563
Market cap: 332913165.84000003 (Small Cap ($300M-$2B))
Debt to equity: 68.44210526316358
Free cash flow (dilution adjusted): -1073521.850899743
Operating income: -7642802.056555269
Net income: -8713367.609254498
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 1452.T (annual, report date 2025-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 925999690 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7196.T (annual, report date 2026-01-31)
Altman Z-score: 1.806293018055486 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.11975077891912%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.9573543792555647%
Free cash flow margin: 2.795196513843083%
Revenue growth: 5.551715385060138%
Rule of 40 score: 8.34691189890322
Market cap: 6475571524 (Mid Cap ($2B-$10B))
P/E ratio: 52.45458946464589
Debt to equity: 0.0933165461127187
Free cash flow (dilution adjusted): 2327624.706189606
Operating income: -412666.49255680334
Net income: 806026.3776442936
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 8365.HK (annual, report date 2025-09-30)
Altman Z-score: 5.770401500120425 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -38.289836827579535%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.182738395560042%
Free cash flow margin: 11.889238321699777%
Revenue growth: -8.603149946127452%
Rule of 40 score: 3.2860883755723247
Market cap: 381598924.8 (Small Cap ($300M-$2B))
Debt to equity: 0.1651845772449213
Free cash flow (dilution adjusted): 1195372.7506426736
Operating income: -2475449.8714652956
Net income: -6121593.83033419
Long score: 8 | Short score: 5
Recommendation: Long
Stock screener scorecard for ALF.L (annual, report date 2024-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.168951595573905%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 0 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -698260
Net income: -2686758
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for APGE (annual, report date 2025-12-31)
Altman Z-score: 83.70385427101074 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -28.717433561644594%
Capitalized R&D asset: 349761470
ROCI (R&D adjusted): -17.570970364562832%
Rule of 40 score: 0
Market cap: 4690341012.84 (Mid Cap ($2B-$10B))
Debt to equity: 0.00978998388065712
Free cash flow (dilution adjusted): -278874000
Operating income: -285595000
Net income: -255843000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ASTI (annual, report date 2025-12-31)
Altman Z-score: -106.21100601064869 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -217.4161043380665%
Capitalized R&D asset: 5048182.550000001
ROCI (R&D adjusted): -88.14464824163778%
Rosenberg metric: -0.005682875058454167
Free cash flow margin: -10511.122399802014%
Revenue growth: 83.2597331296398%
Rule of 40 score: -10427.862666672374
Market cap: 40345531.410000004 (Nano Cap (< $50M))
Debt to equity: 0.4388670667846269
Free cash flow (dilution adjusted): -8069704
Operating income: -7874381
Net income: -7832755
Long score: 3 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CBIO (annual, report date 2025-12-31)
Altman Z-score: 5.004389211521727 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -76.24032076921561%
Capitalized R&D asset: 138086000
ROCI (R&D adjusted): -17.696005827127887%
Free cash flow margin: -1454.7307266691257%
Rule of 40 score: -1454.7307266691257
Market cap: 438343595.65999997 (Small Cap ($300M-$2B))
Debt to equity: 0.008098043465410912
Free cash flow (dilution adjusted): -157751000
Operating income: -152632000
Net income: -153942000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for CNTN (annual, report date 2025-12-31)
Altman Z-score: 0.8650588624710016 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 8531348.540000001
ROCI (R&D adjusted): -4.075963082198427%
Rule of 40 score: 0
Market cap: 233681429.51999998 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -96578739
Operating income: -20106066
Net income: -35916250
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for DTSS (annual, report date 2025-06-30)
Altman Z-score: 12.910145334255688 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 186659.51922476027
ROCI (R&D adjusted): -109.07703936260074%
Rosenberg metric: 5.576661637561362
Free cash flow margin: -11.663068815398397%
Revenue growth: 202.86979773629866%
Rule of 40 score: 191.20672892090028
Market cap: 89678608.7994 (Micro Cap ($50M-$300M))
Debt to equity: 0.9073932897037758
Free cash flow (dilution adjusted): -1164953.8354253836
Operating income: -718928.1729428173
Net income: -709301.8131101814
Long score: 8 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FBF.V (annual, report date 2025-06-30)
Altman Z-score: 11.963954260463034 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.329317657844518%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.62523468069835%
Free cash flow margin: 2.71338817943248%
Revenue growth: 1.0928552083787206%
Rule of 40 score: 3.8062433878112008
Market cap: 12385584.450000001 (Nano Cap (< $50M))
P/E ratio: 22.652523666517915
Debt to equity: 0.022103949024466416
Free cash flow (dilution adjusted): 93743.06569343065
Operating income: 462254.0145985401
Net income: 399097.8102189781
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FINV (annual, report date 2025-12-31)
Altman Z-score: 2.6518978968068847 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.739838825646462%
Capitalized R&D asset: 145967426.69705302
ROCI (R&D adjusted): 13.28697394090084%
Rosenberg metric: 0.891021805025911
Free cash flow margin: 11.944400286306422%
Revenue growth: 8.439611639114307%
Rule of 40 score: 20.38401192542073
Market cap: 4227647828.88 (Mid Cap ($2B-$10B))
P/E ratio: 1.6610264446122547
Debt to equity: 0.07860223354482522
Free cash flow (dilution adjusted): 232171857.14285713
Operating income: 423425142.85714287
Net income: 363600285.71428573
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FPH (annual, report date 2025-12-31)
Altman Z-score: 1.3936086276294992 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 25.428897502324173%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.24948839345413776%
Free cash flow margin: 88.7284130158153%
Revenue growth: -53.758731706496974%
Rule of 40 score: 34.96968130931833
Market cap: 404753374.74 (Small Cap ($300M-$2B))
P/E ratio: 2.2053318444538883
Debt to equity: 0.18561029156877093
Free cash flow (dilution adjusted): 97619000
Operating income: -7388000
Net income: 183534000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for IMMOU.BR (annual, report date 2025-03-31)
Altman Z-score: 0.5648023173299475 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.225806451612903%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.388064464656135%
Free cash flow margin: 56.925774400935126%
Revenue growth: -1.9502366163856792%
Rule of 40 score: 54.975537784549445
Market cap: 13526369.48 (Nano Cap (< $50M))
P/E ratio: 17.70467209424084
Debt to equity: 0.8843090402230188
Free cash flow (dilution adjusted): 2117391.304347826
Operating income: 2092391.304347826
Net income: 830434.7826086956
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IPCX (annual, report date 2025-12-31)
Altman Z-score: 10.395175479457754 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.20251466626989584%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.505909125999613%
Rule of 40 score: 0
Market cap: 264045600 (Micro Cap ($50M-$300M))
P/E ratio: 529.7695098070689
Debt to equity: 7.598119360628576e-07
Free cash flow (dilution adjusted): -4023875
Operating income: -6532315
Net income: 498416
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for M3M.AX (quarterly, report date 2024-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -48.020165911654146%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -50.07491830073598%
Rule of 40 score: 0
Market cap: 8352214.960000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -558632.9192546584
Operating income: -616914.9068322981
Net income: -591454.6583850931
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for MRCY (annual, report date 2025-06-30)
Altman Z-score: 2.857015988246523 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 171440430
ROCI (R&D adjusted): -1.5334336331202951%
Rosenberg metric: 0.5782508289909996
Free cash flow margin: 8.676235170281354%
Revenue growth: 9.187991978689652%
Rule of 40 score: 17.864227148971004
Market cap: 3233931222.38 (Mid Cap ($2B-$10B))
Debt to equity: 0.43722772438496843
Free cash flow (dilution adjusted): 79129000
Operating income: -10414000
Net income: -37904000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for MTG (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.458739699713513%
Capitalized R&D asset: 0
Free cash flow margin: 68.17043990125539%
Revenue growth: 0.48893338003247416%
Rule of 40 score: 68.65937328128787
Market cap: 6109953842.52 (Mid Cap ($2B-$10B))
P/E ratio: 8.275179343208546
Debt to equity: 0.12552337995291354
Free cash flow (dilution adjusted): 827341000
Net income: 738347000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for MYI (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 655367094.86 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PACS.L (annual, report date 2025-03-31)
Altman Z-score: -378.8728423554813 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2888000.0000000005%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17500.000000000175%
Rule of 40 score: 0
Market cap: 7182.9007 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): 335064.93506493507
Operating income: -227272.72727272726
Net income: -37225974.02597403
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for SOI.L (annual, report date 2025-08-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.907614448944468%
Capitalized R&D asset: 0
Free cash flow margin: 66.45619493025778%
Revenue growth: -11.553918285331548%
Rule of 40 score: 54.90227664492623
Market cap: 6518534.7486 (Nano Cap (< $50M))
P/E ratio: 0.06898212356713512
Debt to equity: 0.050550816492395116
Free cash flow (dilution adjusted): 87755405.4054054
Net income: 127697297.2972973
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for SRC.V (annual, report date 2025-12-31)
Altman Z-score: 13.550446059634547 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -65.96784805535711%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -59.93529788949785%
Free cash flow margin: -201.87413931025665%
Revenue growth: 78.3398583797648%
Rule of 40 score: -123.53428093049185
Market cap: 20172168.72 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2374383.211678832
Operating income: -1747985.4014598539
Net income: -1910545.9854014597
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for TRTX (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.255108738294962%
Capitalized R&D asset: 0
Free cash flow margin: 49.191197371639355%
Revenue growth: 0.058206832688428085%
Rule of 40 score: 49.24940420432778
Market cap: 627742657.0799999 (Small Cap ($300M-$2B))
P/E ratio: 10.407046819078564
Debt to equity: 3.0795291861692116
Free cash flow (dilution adjusted): 74413000
Net income: 60319000
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TWM.TO (annual, report date 2025-12-31)
Altman Z-score: 0.4749137776931306 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -39.07793633369923%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.297656029370234%
Free cash flow margin: 2.3359878649981036%
Revenue growth: -16.108227641118848%
Rule of 40 score: -13.772239776120745
Market cap: 115263495.12 (Micro Cap ($50M-$300M))
Debt to equity: 2.647167204053431
Free cash flow (dilution adjusted): 22481751.824817516
Operating income: -32554744.52554744
Net income: -81897810.21897809
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TWST (annual, report date 2025-09-30)
Altman Z-score: 3.6843522873747148 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.418728036932404%
Capitalized R&D asset: 176430860
ROCI (R&D adjusted): -20.45039093207839%
Rosenberg metric: 0.6345815171927971
Free cash flow margin: -37.20165068034798%
Revenue growth: 20.320537808252443%
Rule of 40 score: -16.88111287209554
Market cap: 1752314775.96 (Small Cap ($300M-$2B))
Debt to equity: 0.15978585836374476
Free cash flow (dilution adjusted): -140091000
Operating income: -136259000
Net income: -77670000
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for VIS.V (annual, report date 2025-09-30)
Altman Z-score: -141.65022187317095 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -187.02459816985737%
Revenue growth: -14.573773415017788%
Rule of 40 score: -201.59837158487517
Market cap: 5166526.7 (Nano Cap (< $50M))
Debt to equity: -0.4944535671582303
Free cash flow (dilution adjusted): -582710.7913669065
Operating income: -759036.690647482
Net income: -775228.7769784173
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for 0064.HK (annual, report date 2026-03-31)
Altman Z-score: 4.214081438543498 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.1102701573891163%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.757305315861163%
Free cash flow margin: -46.88138685551363%
Revenue growth: -8.227335517854032%
Rule of 40 score: -55.10872237336766
Market cap: 2342967552 (Mid Cap ($2B-$10B))
P/E ratio: 4.350907029478458
Debt to equity: 0
Free cash flow (dilution adjusted): -18813010.204081632
Operating income: 23416454.081632655
Net income: 6814413.265306123
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 0064.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2342967552 (Mid Cap ($2B-$10B))
P/E ratio: 4.350907029478458
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0371.HK (annual, report date 2025-12-31)
Altman Z-score: 0.5596049274998414 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 20.245288950880933%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.869802048408121%
Free cash flow margin: 20.885996111621214%
Revenue growth: -9.332577138735832%
Rule of 40 score: 11.553418972885382
Market cap: 23566059520 (Large Cap ($10B-$200B))
P/E ratio: 1.799485861182519
Debt to equity: 1.3547
Free cash flow (dilution adjusted): 592275064.2673522
Operating income: 599009897.1722364
Net income: 346058354.75578403
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0371.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23566059520 (Large Cap ($10B-$200B))
P/E ratio: 1.799485861182519
Debt to equity: 1.3547
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0550.HK (annual, report date 2025-12-31)
Altman Z-score: 28.387707009307587 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.224267139227532%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.360866450335033%
Free cash flow margin: -6.26403177657711%
Revenue growth: 156.5686311696352%
Rule of 40 score: 150.3045993930581
Market cap: 646858304 (Small Cap ($300M-$2B))
Debt to equity: 0.0281
Free cash flow (dilution adjusted): -652699.2287917738
Operating income: -205012.85347043702
Net income: -698329.0488431876
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 0550.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 646858304 (Small Cap ($300M-$2B))
Debt to equity: 0.0281
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0959.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 92338248 (Micro Cap ($50M-$300M))
Debt to equity: -0.8845194647201947
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1097.HK (annual, report date 2025-12-31)
Altman Z-score: -1.4248761704549127 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -57.555885131761386%
Revenue growth: -8.064297730488281%
Rule of 40 score: -65.62018286224966
Market cap: 456615936 (Small Cap ($300M-$2B))
Debt to equity: -1.1482200778189122
Free cash flow (dilution adjusted): -39855526.99228792
Operating income: -46311182.5192802
Net income: -62979177.37789203
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 1097.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 456615936 (Small Cap ($300M-$2B))
Debt to equity: -1.1482200778189122
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1289.HK (annual, report date 2025-12-31)
Altman Z-score: 2.1464748671398732 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.03114934675609%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.540901371049527%
Free cash flow margin: 19.817479855545557%
Revenue growth: -62.7297389104997%
Rule of 40 score: -42.91225905495414
Market cap: 268800000 (Micro Cap ($50M-$300M))
P/E ratio: 1.094618127539597
Debt to equity: 0
Free cash flow (dilution adjusted): 5221000
Operating income: 2673714.285714286
Net income: 4829857.142857143
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1289.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 268800000 (Micro Cap ($50M-$300M))
P/E ratio: 1.094618127539597
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1314.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 247785200 (Micro Cap ($50M-$300M))
P/E ratio: 1.913265306122449
Debt to equity: 0.5574
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1314.HK (annual, report date 2026-03-31)
Altman Z-score: 0.8855999331130544 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.273317130285918%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.45497715787722925%
Free cash flow margin: 13.291838225716019%
Revenue growth: -3.3068507247055767%
Rule of 40 score: 9.984987501010442
Market cap: 247785200 (Micro Cap ($50M-$300M))
P/E ratio: 1.913265306122449
Debt to equity: 0.5574
Free cash flow (dilution adjusted): 14967474.48979592
Operating income: -373341.8367346939
Net income: 1183801.0204081633
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2317.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1065919424 (Small Cap ($300M-$2B))
P/E ratio: 0.8854612967723507
Debt to equity: 0.10039999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2483.T (annual, report date 2026-03-31)
Altman Z-score: 5.883594409385328 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.116977788238877%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.710288907627238%
Free cash flow margin: 5.080414251780074%
Revenue growth: -9.222005397086777%
Rule of 40 score: -4.141591145306703
Market cap: 7720624128 (Mid Cap ($2B-$10B))
P/E ratio: 0.08214827297356149
Debt to equity: 0.0023
Free cash flow (dilution adjusted): 3455424.1741741737
Operating income: 4415628.128128128
Net income: 2891654.154154154
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 2483.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7720624128 (Mid Cap ($2B-$10B))
P/E ratio: 0.08214827297356149
Debt to equity: 0.0023
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 256A.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 39569526784 (Large Cap ($10B-$200B))
P/E ratio: 0.05141654357348379
Debt to equity: 0.6607
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3656.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 17745051648 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3951.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18300882944 (Large Cap ($10B-$200B))
P/E ratio: 0.07217486758141456
Debt to equity: 0.5508
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4098.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3089540608 (Mid Cap ($2B-$10B))
P/E ratio: 0.1010703757068862
Debt to equity: 0.6498
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4098.T (annual, report date 2026-03-31)
Altman Z-score: 1.2128717936687172 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.022903653227333%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.4490714038528094%
Free cash flow margin: 9.178031699225949%
Revenue growth: -2.2504365412371605%
Rule of 40 score: 6.927595157988788
Market cap: 3089540608 (Mid Cap ($2B-$10B))
P/E ratio: 0.1010703757068862
Debt to equity: 0.6498
Free cash flow (dilution adjusted): 4673423.423423423
Operating income: 1870620.6206206207
Net income: 1482732.7327327328
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4235.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11070452736 (Large Cap ($10B-$200B))
P/E ratio: 0.11615793989894709
Debt to equity: 1.6856
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4433.T (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15719154688 (Large Cap ($10B-$200B))
P/E ratio: 0.23481540829479094
Debt to equity: 0.35840000000000005
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4465.T (annual, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13316399104 (Large Cap ($10B-$200B))
P/E ratio: 0.043487866577112566
Debt to equity: 0.0673
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5393.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 634367574016 (Mega Cap (>= $200B))
P/E ratio: 0.10904343749582562
Debt to equity: 0.046
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6926.T (annual, report date 2026-03-31)
Altman Z-score: 0.8952570142590472 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.009599861189965%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -18.95260232938705%
Free cash flow margin: -13.19908073701764%
Revenue growth: -0.25032361387586843%
Rule of 40 score: -13.44940435089351
Market cap: 4185776896 (Mid Cap ($2B-$10B))
Debt to equity: 0.7522
Free cash flow (dilution adjusted): -8446477.727727728
Operating income: -10874468.218218219
Net income: -10148404.654654654
Long score: 1 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 6926.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4185776896 (Mid Cap ($2B-$10B))
Debt to equity: 0.7522
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7079.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6339189760 (Mid Cap ($2B-$10B))
P/E ratio: 0.05745270360600532
Debt to equity: 0.0165
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7079.T (annual, report date 2026-03-31)
Altman Z-score: 7.474230083492368 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.921318650779867%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.887869823419283%
Free cash flow margin: 10.823696850355278%
Revenue growth: -15.373459412825847%
Rule of 40 score: -4.549762562470569
Market cap: 6339189760 (Mid Cap ($2B-$10B))
P/E ratio: 0.05745270360600532
Debt to equity: 0.0165
Free cash flow (dilution adjusted): 3261067.3173173172
Operating income: 5988513.513513514
Net income: 4249912.412412412
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7320.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15076676608 (Large Cap ($10B-$200B))
Debt to equity: 0.43439999999999995
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8300.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 66084000 (Micro Cap ($50M-$300M))
Debt to equity: -0.2979764581404576
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8348.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 106137008 (Micro Cap ($50M-$300M))
Debt to equity: 0.22190000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8348.HK (annual, report date 2025-12-31)
Altman Z-score: 1.981462808194518 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.542992207080842%
Free cash flow margin: 4.78615605363416%
Revenue growth: -43.19364493959553%
Rule of 40 score: -38.40748888596137
Market cap: 106137008 (Micro Cap ($50M-$300M))
Debt to equity: 0.22190000000000001
Free cash flow (dilution adjusted): 13819000
Operating income: -8211285.714285715
Net income: -4948857.142857143
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8510.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 41564896 (Nano Cap (< $50M))
Debt to equity: -0.27311057236217984
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 8510.HK (annual, report date 2025-12-31)
Altman Z-score: -15.604391190812827 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 6.428861376090928%
Revenue growth: 37.2144126827129%
Rule of 40 score: 43.643274058803826
Market cap: 41564896 (Nano Cap (< $50M))
Debt to equity: -0.27311057236217984
Free cash flow (dilution adjusted): 162853.470437018
Operating income: 431619.5372750643
Net income: -118766.06683804627
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 9324.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 73097314304 (Large Cap ($10B-$200B))
P/E ratio: 0.06432545688299614
Debt to equity: 0.7254
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AFRI (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 283389728 (Micro Cap ($50M-$300M))
Debt to equity: 23.942600000000002
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AFRI (annual, report date 2025-12-31)
Altman Z-score: -0.17893925821590062 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.03591490226978%
Free cash flow margin: -0.5711436471601469%
Revenue growth: -35.640701181155485%
Rule of 40 score: -36.211844828315634
Market cap: 283389728 (Micro Cap ($50M-$300M))
Debt to equity: 23.942600000000002
Free cash flow (dilution adjusted): -1008000
Operating income: -3555000
Net income: -13790000
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for ALPM.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 132997688 (Micro Cap ($50M-$300M))
P/E ratio: 15.189800057954217
Debt to equity: 0.1773
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALQWA.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8462510 (Nano Cap (< $50M))
P/E ratio: 10.40247678018576
Debt to equity: 0.1295
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALQWA.PA (annual, report date 2025-12-31)
Altman Z-score: 1.3542515174863823 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 35.48549636652078%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.529277221102961%
Free cash flow margin: 7.953495550168036%
Revenue growth: -4.3501752688244615%
Rule of 40 score: 3.6033202813435743
Market cap: 8462510 (Nano Cap (< $50M))
P/E ratio: 10.40247678018576
Debt to equity: 0.1295
Free cash flow (dilution adjusted): 2639861.1764705884
Operating income: 1127494.1176470588
Net income: 1242781.1764705882
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for ANCR.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 230268224 (Micro Cap ($50M-$300M))
P/E ratio: 0.45752895752895756
Debt to equity: 0.1328
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AOK.AX (annual, report date 2025-12-31)
Altman Z-score: -29.871510698365793 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -239.9098780250105%
Free cash flow margin: -954.0057702355799%
Revenue growth: -54.98180465701127%
Rule of 40 score: -1008.9875748925912
Market cap: 4866941 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1409207.3825503355
Operating income: -2511267.11409396
Net income: -1906067.7852348993
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AOK.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4866941 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BOC (quarterly, report date 2026-03-31)
Altman Z-score: 1.5679303861976532 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.2888901712422638%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.34731981214583035%
Free cash flow margin: -9.458741902368226%
Revenue growth: -4.910587710734433%
Rule of 40 score: -14.369329613102659
Market cap: 429352256 (Small Cap ($300M-$2B))
Debt to equity: 0.20190000000000002
Free cash flow (dilution adjusted): -2672000
Operating income: -2212000
Net income: -2149000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for CARM.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2286018816 (Mid Cap ($2B-$10B))
Debt to equity: 0.787820438539269
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CARM.PA (annual, report date 2025-12-31)
Altman Z-score: 0.9110879657831137 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.903965061588825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.355364378199709%
Free cash flow margin: 53.5186771729978%
Revenue growth: 21.181288422576994%
Rule of 40 score: 74.6999655955748
Market cap: 2286018816 (Mid Cap ($2B-$10B))
P/E ratio: 11.627787430025442
Debt to equity: 0.787820438539269
Free cash flow (dilution adjusted): 342472941.1764706
Operating income: 398415294.11764705
Net income: 218692941.1764706
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CDPR.V (annual, report date 2026-03-31)
Altman Z-score: 124.82706153880552 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.953212789050397%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -26.510525162704706%
Rule of 40 score: 0
Market cap: 384990144 (Small Cap ($300M-$2B))
Debt to equity: 0.0021
Free cash flow (dilution adjusted): -8709058.273381295
Operating income: -5861345.323741008
Net income: -2956987.769784173
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CDPR.V (quarterly, report date 2026-03-31)
Altman Z-score: 125.42806602188399 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.85377042122789%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.252247959136293%
Rule of 40 score: 0
Market cap: 384990144 (Small Cap ($300M-$2B))
Debt to equity: 0.0021
Free cash flow (dilution adjusted): -3074400.7194244605
Operating income: -1603435.9712230216
Net income: -227814.38848920865
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CNQ.TO (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 136572297216 (Large Cap ($10B-$200B))
P/E ratio: 8.718801132379296
Debt to equity: 0.4485
Free cash flow (dilution adjusted): 392805755.39568347
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTRM (quarterly, report date 2026-03-31)
Altman Z-score: 0.8327430867762096 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.068139790835817%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.2625596757486806%
Free cash flow margin: 39.659055425026565%
Revenue growth: -7.959703610905942%
Rule of 40 score: 31.699351814120625
Market cap: 18068602 (Nano Cap (< $50M))
P/E ratio: 0.5489614243323442
Debt to equity: 0.1366
Free cash flow (dilution adjusted): 9690458.620689655
Operating income: 2585032.1839080458
Net income: 79560713.79310344
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CYVIZ.OL (quarterly, report date 2026-03-31)
Altman Z-score: 0.484364690435406 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -23.261704109215636%
Free cash flow margin: -9.045141958477961%
Revenue growth: -45.52116682174882%
Rule of 40 score: -54.566308780226784
Market cap: 324350464 (Small Cap ($300M-$2B))
Debt to equity: 0.7605
Free cash flow (dilution adjusted): -998972.2507708119
Operating income: -2104933.196300103
Net income: -2272867.4203494345
Long score: 1 | Short score: 12
Recommendation: Short
Stock screener scorecard for DHR.V (quarterly, report date 2026-03-31)
Altman Z-score: -108.57653882708638 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -335.81036643627385%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -41.223150135878%
Rule of 40 score: 0
Market cap: 1453583.6099999999 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -55740.287769784176
Operating income: -47799.280575539575
Net income: -389380.5755395684
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DLHC (quarterly, report date 2026-03-31)
Altman Z-score: 0.4927672327736744 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.023462061845995027%
Free cash flow margin: 5.34716949295537%
Revenue growth: -13.974046333391396%
Rule of 40 score: -8.626876840436026
Market cap: 73769552 (Micro Cap ($50M-$300M))
Debt to equity: 1.3202
Free cash flow (dilution adjusted): 3169000
Operating income: -55000
Net income: -2535000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for DMP.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1572797952 (Small Cap ($300M-$2B))
P/E ratio: 19.138071895424837
Debt to equity: 1.8099
Long score: 0 | Short score: 2
Recommendation: Neutral